Acute Decompensated Heart Failure Flashcards

1
Q

HF

What are the pharmacologic recommendations for patients at risk for HF?

A
  • pt with HTN= control BP
  • pt with T2DM and w/ CVD or at high risk for CVD= SGLT2i
  • pt with CVD= optimal management of CVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF

What are the pharmacologic recommendations for patients with pre-HF (Stage B)?

A

pt with LVEF 40% or less= ACEi or ARB is ACEi intolerant and beta blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HF

What is initial pharmacologic treatment for HFrEF stage C/D?

A
  • ARNi or ACEi/ARB
  • beta blocker
  • mineralcorticoid receptor antagonist (MRA)
  • SGLT2i
  • diuretics PRN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HF

Define: Acute Decompensated HF

A

worsening of heart failure requiring hospitalization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HF

What are the precipitating factors of HF?

A
  • acute coronary syndrome (ACS)
  • uncontrolled HTN
  • atrial fibrillation (arrhythmias)
  • dietary or medication non-adherence
  • anemias
  • acute infections
  • hyper/hypo-thyroidism
  • harmful medication use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HF

What medications contribute to fluid overload?

A
  • NSAIDs
  • COX-2 inhibitors
  • glucocorticoids
  • minoxidil
  • TZDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HF

What medications contribute to decreased perfusion?

A
  • new or high doses of anti-hypertensives
  • excessive diuretic use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HF

What medications can worsen HF due to negative inotrope properties?

A
  • antiarrhythmics
  • non-DHP calcium channel blockers (verapamil and diltiazem)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HF

How may a patient present with ADHF with congestion/fluid overload?

A
  • edema
  • dyspnea
  • orthopnea
  • elevated jugular venous pressure
  • pulmonary rales/crackles
  • S3 gallop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HF

How may a patient present with ADHF with low perfusion?

A
  • narrow pulse pressure
  • cool extremeties
  • hypotension
  • tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HF

What laboratory values/diagnostic test can assist in identifying ADHF?

A
  • BNP or NT-proBNP!!!
  • serum sodium
  • LFT
  • urine output
  • BUN/serum creatinine
  • chest xray
  • TTE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HF

What device can allow for more objective fluid overload status?

A

flow-directed pulmonary artery catheter (Swan-Ganz catheter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HF

What does a pulmonary capillary wedge pressure > 18 mmHg indicate?

A

congestion/fluid overload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HF

What does a reduced cardiac index of < 2.2 L/min/m2 indicate?

A

low cardiac output/low perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HF

What does “warm” mean?

A

low perfusion NOT observed= cardiac index normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HF

What does “cold” mean?

A

low perfusion= cardiac index <2.2 L/min/m2, signs/symptoms include narrow pulse pressure, cool extremeties, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HF

What does “dry” mean?

A

congestion at rest not present= capillary wedge pressure normal

17
Q

HF

What does “wet” mean?

A

congestion at rest= capillary wedge pressure > 18 mmHg, signs/symptoms include orthopnea, elevated jugular venous, pulmonary rales, S3 gallop, edema, dyspnea

18
Q

HF

What drugs may be used to treat fluid overload?

A
  • loop diuretics
  • thiazide diuretics
  • venodilators (nitroglycerin/nitroprusside)
19
Q

HF

What drugs may be used to treat low cardiac output?

A
  • positive inotropes (dobutamine/milrinone)
  • arterial vasodialators (nitroprusside)
20
Q

HF

What is the initial pharmacologic management for congestion/fluid overload?

A

IV loop diuretics

21
Q

HF

What are the preferred loop diuretics for decongestion?

A

furosemide, bumetanide, torsemide(not avaliable IV)

22
Q

HF

What is the goal response with loop diuretics?

A

> 500 mL urine output within 2 hours

23
Q

HF

What is the recommended dosing for loop diuretics for decongestion?

A

intermittent or continuous IV at equal or greater dose of the patients daily chronic dose

24
Q

HF

What are the monitoring parameters while on loop diuretics?

A
  • fluid intake and output
  • vital signs
  • body weight
  • electrolytes, BUN, SCr
25
Q

HF

How can “diuretic resistance” be overcome?

A
  • higher doses of loops
  • addition of second diuretic
  • ultrafiltration
  • low-does dobutamine
  • vasopressin antagonist
  • vasodilators
26
Q

HF

What is the role of thiazide diuretics in ADHF?

A

may be used for congestion when loops are inadequate, adjunct therapy, close monitoring required

27
Q

HF

What is the role of vasodilators for ADHF?

A

add on therapy for refractory congestion, hypotension must not be present

28
Q

HF

What vasodilators may be used for congestion?

A
  • nitroglycerin (venodilator)
  • sodium nitropusside (venodialator + arterial vasodilator)
29
Q

HF

What patients are ideal for nitroglycerin use in congestion?

A

pt with hypertension, coronary ischemia or significant mitral regurgitation

30
Q

HF

What are the warnings/precautions associated with nitroglycerin?

A
  • tachyphylaxis
  • hypotension
  • elevated intracranial pressure
31
Q

HF

What patients are ideal for sodium nitroprusside use in congestion?

A

severe congestion with hypertension or severe mitral valve regurgitation

32
Q

HF

What are the warnings/precautions associated with sodium nitroprusside?

A
  • requires invasive BP monitoring!!!
  • renal insufficiency
  • rebound phenomenon
  • elevated intracranial pressure
33
Q

HF

What is the recommendation for using inotropes for low perfusion?

A

not to be used long-term, but can be used in patients with cardiogenic shock as a bridge therapy

34
Q

HF

What drugs are inotropes that may potentially be used for low perfusion?

A

dobutamine and milirone

35
Q

HF

What is the mechanism of dobutamine?

A

adrenergic agonist, primarly beta1and beta2, some alpha1

36
Q

HF

What is the mechanism of milrinone?

A

vasodilator via PDE inhibition

37
Q

HF

What are the adverse effects of dobutamine?

A
  • tachyarrhythmias
  • BP instability
  • headache
  • nausea
  • fever
38
Q

HF

What are the adverse effects of milrinone?

A
  • arrhythmias
  • hypotension
  • thrombocytopenia
39
Q

HF

What are the monitoring parameters for patients with ADHF?

A
  • daily weights
  • I/O
  • electrolytes (Na+/K+/Ca2+/Mg2+)
  • SCr/BUN
  • vital signs
  • physical exam
  • BNP, NT-proBNP